Publications
Detailed Information
Angiogenesis Imaging Using (68)Ga-RGD PET: Preliminary Report from Seoul National University Hospital
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Ho Young | - |
dc.contributor.author | Kang, Keon Wook | - |
dc.contributor.author | Kim, Tae-You | - |
dc.contributor.author | Lee, Yun-Sang | - |
dc.contributor.author | Han, Sae-Won | - |
dc.contributor.author | Chung, June-Key | - |
dc.contributor.author | Lee, Dong Soo | - |
dc.contributor.author | Lee, Myung Chul | - |
dc.contributor.author | Paeng, Jin Chul | - |
dc.contributor.author | Jeong, Jae Min | - |
dc.date.accessioned | 2012-06-26T06:38:00Z | - |
dc.date.available | 2012-06-26T06:38:00Z | - |
dc.date.issued | 2010-02 | - |
dc.identifier.citation | CURRENT MEDICAL IMAGING REVIEWS; Vol.6 1; 56-59 | ko_KR |
dc.identifier.issn | 1573-4056 | - |
dc.identifier.uri | https://hdl.handle.net/10371/77463 | - |
dc.description.abstract | In cancer treatment, molecular targeting therapy has rapidly progressed. With the improvement of molecular targeting therapy, the need for evaluating bio-marker is increasing. To decide appropriate target agent, evaluating the status of target molecule is mandatory. Anti-angiogenic therapy is widely used as a clinical strategy for cancer treatment such as colorectal cancer, lung cancer. In case of anti-angiogenic treatment, angiogenesis imaging could select the patients who respond to anti-angiogenic treatment. There are several methods to evaluate angiogenesis. Angiogenesis could be evaluated by vascular structure, hemodynamic changes. However, none of those parameters are present in the angiogenic activity of tumor. Furthermore, the results of vascular structure or hemodynamic changes could not predict the response. RGD peptide is a ligand of integrin alpha v beta 3 which over-expresses on the endothelium of neo-vascularization. Using radiolabeled RGD PET, we could evaluate the angiogenic activity of tumor, and it could be related with the response to anti-angiogenic drugs. In this paper, we summarized the factors predicting the response. In this paper, we also introduced our preliminary experience of (68)Ga-RGD PET in patients with colorectal cancer. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | BENTHAM SCIENCE PUBL LTD | ko_KR |
dc.subject | Angiogenesis | ko_KR |
dc.subject | FDG | ko_KR |
dc.subject | RGD | ko_KR |
dc.subject | Positron emission tomography | ko_KR |
dc.title | Angiogenesis Imaging Using (68)Ga-RGD PET: Preliminary Report from Seoul National University Hospital | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 이호영 | - |
dc.contributor.AlternativeAuthor | 강건욱 | - |
dc.contributor.AlternativeAuthor | 김태유 | - |
dc.contributor.AlternativeAuthor | 이윤상 | - |
dc.contributor.AlternativeAuthor | 정재민 | - |
dc.contributor.AlternativeAuthor | 한새원 | - |
dc.contributor.AlternativeAuthor | 팽진철 | - |
dc.contributor.AlternativeAuthor | 정준기 | - |
dc.contributor.AlternativeAuthor | 이명철 | - |
dc.contributor.AlternativeAuthor | 이동수 | - |
dc.citation.journaltitle | CURRENT MEDICAL IMAGING REVIEWS | - |
dc.description.citedreference | Turkbey B, 2009, AM J ROENTGENOL, V193, P304, DOI 10.2214/AJR.09.2869 | - |
dc.description.citedreference | Rimassa L, 2009, EXPERT REV ANTICANC, V9, P739, DOI 10.1586/ERA.09.41 | - |
dc.description.citedreference | JEONG JM, 2009, NUCL MED MOL IMAGING, V43, P330 | - |
dc.description.citedreference | Haubner R, 2009, FRONT BIOSCI, V14, P872, DOI 10.2741/3283 | - |
dc.description.citedreference | DIJKGRAAF I, 2009, FRONT BIOSCI, V1, P887 | - |
dc.description.citedreference | Jiang HJ, 2008, HEPATOB PANCREAT DIS, V7, P497 | - |
dc.description.citedreference | Li ZB, 2008, EUR J NUCL MED MOL I, V35, P1100, DOI 10.1007/s00259-007-0692-y | - |
dc.description.citedreference | Jeong JM, 2008, J NUCL MED, V49, P830, DOI 10.2967/jnumed.107.047423 | - |
dc.description.citedreference | Beer AJ, 2008, J NUCL MED, V49, P22, DOI 10.2967/jnumed.107.045864 | - |
dc.description.citedreference | Zhernosekov KP, 2007, J NUCL MED, V48, P1741, DOI 10.2967/jnumed.107.040378 | - |
dc.description.citedreference | Li ZB, 2007, J NUCL MED, V48, P1162, DOI 10.2967/jnumed.107.039859 | - |
dc.description.citedreference | Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115 | - |
dc.description.citedreference | Motzer RJ, 2007, NEW ENGL J MED, V356, P115 | - |
dc.description.citedreference | Beer AJ, 2006, CLIN CANCER RES, V12, P3942, DOI 10.1158/1078-0432.CCR-06-0266 | - |
dc.description.citedreference | Rufini V, 2006, SEMIN NUCL MED, V36, P228, DOI 10.1053/j.semnuclmed.2006.03.007 | - |
dc.description.citedreference | Beer AJ, 2006, J NUCL MED, V47, P763 | - |
dc.description.citedreference | Beer AJ, 2005, J NUCL MED, V46, P1333 | - |
dc.description.citedreference | Chen XY, 2005, NEOPLASIA, V7, P271, DOI 10.1593/neo.04538 | - |
dc.description.citedreference | Haubner R, 2004, BIOCONJUGATE CHEM, V15, P61, DOI 10.1021/bc034170n | - |
dc.description.citedreference | Hamano Y, 2003, CANCER CELL, V3, P589 | - |
dc.description.citedreference | CAI W, 2003, CURR PHARMS DES, V90, P577 | - |
dc.description.citedreference | Carmeliet P, 2000, NATURE, V407, P249 | - |
dc.description.citedreference | Bafetti LM, 1998, J BIOL CHEM, V273, P143 | - |
dc.description.citedreference | BROOKS PC, 1994, SCIENCE, V264, P569 | - |
dc.description.citedreference | SEFTOR REB, 1992, P NATL ACAD SCI USA, V89, P1557 | - |
dc.description.citedreference | SMITH JW, 1990, J BIOL CHEM, V265, P2168 | - |
dc.description.citedreference | SCHUHMACHER J, 1981, INT J APPL RADIAT IS, V32, P31 | - |
dc.description.citedreference | FOLKMAN K, 1971, NEW ENGL J MED, V285, P1182 | - |
dc.description.tc | 0 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.